Blackstone Reports Q1 Earnings Exceeding Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2026
0mins
Should l Buy BX?
Source: stocktwits
- Earnings Performance: Blackstone reported Q1 earnings of $1.36 per share, surpassing expectations of $1.33, although its private credit funds delivered zero net returns, indicating a mixed business performance.
- Dividend Announcement: The firm declared a dividend of $1.16 per common share payable on May 11, 2026, despite a 6% drop in stock price on Thursday, which slightly recovered in after-hours trading, reflecting investor focus on the dividend.
- Asset Management Scale: Blackstone's total assets under management reached $1.3 trillion, with Q1 revenue increasing by 10% to $3.62 billion; despite declines in returns across certain businesses, the firm attracted $68.5 billion in new assets, demonstrating market resilience.
- Strategic Investment: Executives emphasized that long-term investments in AI infrastructure will be crucial for driving client performance and company growth, even as analysts maintain cautious earnings forecasts, expecting $1.44 per share in Q2.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BX
Wall Street analysts forecast BX stock price to rise
12 Analyst Rating
5 Buy
7 Hold
0 Sell
Moderate Buy
Current: 125.580
Low
166.00
Averages
176.60
High
205.00
Current: 125.580
Low
166.00
Averages
176.60
High
205.00
About BX
Blackstone Inc. is an alternative asset manager. Its asset management includes global investment strategies focused on real estate, private equity, infrastructure, life sciences, growth equity, credit, real assets, secondaries, and hedge funds. Its Real Estate segment comprises its management of opportunistic real estate funds, Core+ real estate funds, and real estate debt strategies. Its Private Equity segment includes its management of flagship Corporate Private Equity funds, sector and geographically focused Corporate Private Equity funds, core private equity funds, an investment platform, and others. Its Credit & Insurance segment consists of Blackstone Credit & Insurance, which is organized into three overarching strategies: private corporate credit, liquid corporate credit and infrastructure and asset-based credit. Its Multi-Asset Investing segment is organized into four investment platforms: Absolute Return, Multi-Strategy, Total Portfolio Management, and Public Real Assets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Blackstone's Outlook on Private Credit Market Amidst Negative Press
- Capital Flow Impact: Blackstone CEO Steve Schwarzman noted that negative press has affected individual investors' capital inflow into its flagship private credit fund, BCRED, while capital commitments from institutional and insurance clients, which represent 75% of its credit AUM, remain unaffected.
- Investment Return Performance: Blackstone has generated an annual net return of 9.4% in its non-investment-grade private credit strategies since inception, nearly double the leveraged loan market's return, demonstrating stability across various market cycles.
- Expansion into Investment-Grade Credit: In the first quarter, Blackstone grew its investment-grade private credit platform by 23% to $130 million in AUM, indicating significant expansion potential in high-quality credit markets, particularly in response to rising capital needs in infrastructure and AI sectors.
- Market Challenge Response: Despite negative headlines prompting some individual investors to withdraw capital, Blackstone's private credit investments continue to perform well, positioning the firm to emerge stronger as the private credit market stabilizes, showcasing its competitive edge in lower-risk fixed-income investments.
See More
Analysis of Capital Outflows from Blackstone's Private Credit Fund
- Capital Outflow: Individual investors have withdrawn capital from Blackstone's flagship private credit fund, BCRED, due to concerns over the investment strategy, although institutional and insurance clients still represent 75% of its credit assets under management.
- Stable Returns: Blackstone has achieved an annual net return of 9.4% in its non-investment-grade private credit strategies since inception, nearly double the leveraged loan market's returns, demonstrating resilience and attractiveness across various market cycles.
- Investment-Grade Expansion: The company grew its investment-grade private credit platform by 23% in the first quarter to $130 million in AUM, indicating a strategic move to leverage its leadership in the non-investment-grade market to explore new investment opportunities.
- Optimistic Market Outlook: Despite negative press, Blackstone remains confident in the investment-grade credit market's future, believing it can continue to deliver premium returns over liquid markets, particularly as capital needs rise in sectors like AI infrastructure development.
See More
BLACKSTONE PRIVATE CREDIT FUND SEEKS SEC APPROVAL FOR UP TO $45 BILLION OFFERING OF CLASS I, CLASS S, AND CLASS D SHARES
- Blackstone Private Credit Fund Filing: Blackstone has filed for an offering of Class I, Class S, and Class D shares of up to $45 billion.
- Investment Opportunity: The filing indicates a significant opportunity for investors to participate in the fund's offerings.
See More
BLACKSTONE PRIVATE CREDIT FUND TO ACQUIRE UP TO 93.1 MILLION SHARES TENDERED BY SHAREHOLDERS AND NOT WITHDRAWN AS OUTLINED IN OFFER
- Fund Purchase Announcement: Blackstone Private Credit Fund plans to purchase up to 93.1 million shares tendered by the fund's shareholders.
- Shareholder Participation: The purchase will be executed for shares that have not been withdrawn, as detailed in the offer.
See More
Blue Owl Capital Shares Surge 9.80% After Strong Q1 Results
- Strong Earnings Beat: Blue Owl Capital reported Q1 2026 earnings with a 14% year-over-year increase to $393.6 million, exceeding market expectations and significantly boosting investor confidence, which led to a share price increase.
- Asset Management Growth: The firm's assets under management rose by 15% to $314.9 billion, indicating robust growth in the private credit sector and enhancing market confidence in its future prospects.
- Surge in Trading Volume: Trading volume reached 68.9 million shares, approximately 100% above the three-month average, reflecting strong market interest and positive investor sentiment towards Blue Owl Capital.
- Market Opportunities: Executives highlighted that despite pressures in private credit, substantial spending by big tech on AI infrastructure presents new opportunities for private credit, which is expected to drive future revenue growth.
See More
Blackstone's $400 Million Investment in Teva: A Strategic Bet
- Investment Scale and Strategic Significance: Blackstone Life Sciences' $400 million investment in Teva Pharmaceuticals in March 2023 reflects strong confidence in the new drug duvakitug, representing not just financial backing but a significant bet on Teva's future development.
- Drug Potential and Clinical Progress: Duvakitug, a monoclonal antibody targeting TL1A, is currently undergoing Phase 3 clinical trials for ulcerative colitis and Crohn's disease, with promising Phase 2 results showing durable efficacy over 44 weeks, indicating a broad market potential.
- Teva's Transformation and Market Recognition: Teva has evolved from a mere generic drug manufacturer to a leader in biopharmaceutical innovation, with credit rating agencies upgrading its rating to BB+, reflecting market confidence in its transformation.
- Opportunities and Risks for Investors: Blackstone's investment not only provides Teva with financial support but may also yield milestone payments and low single-digit royalties on global sales, suggesting that while risk-averse investors might hesitate, aggressive investors could find significant value in Teva, especially if duvakitug succeeds as anticipated.
See More
Blackstone's Outlook on Private Credit Market Amidst Negative Press
- Capital Flow Impact: Blackstone CEO Steve Schwarzman noted that negative press has affected individual investors' capital inflow into its flagship private credit fund, BCRED, while capital commitments from institutional and insurance clients, which represent 75% of its credit AUM, remain unaffected.
- Investment Return Performance: Blackstone has generated an annual net return of 9.4% in its non-investment-grade private credit strategies since inception, nearly double the leveraged loan market's return, demonstrating stability across various market cycles.
- Expansion into Investment-Grade Credit: In the first quarter, Blackstone grew its investment-grade private credit platform by 23% to $130 million in AUM, indicating significant expansion potential in high-quality credit markets, particularly in response to rising capital needs in infrastructure and AI sectors.
- Market Challenge Response: Despite negative headlines prompting some individual investors to withdraw capital, Blackstone's private credit investments continue to perform well, positioning the firm to emerge stronger as the private credit market stabilizes, showcasing its competitive edge in lower-risk fixed-income investments.
See More
Analysis of Capital Outflows from Blackstone's Private Credit Fund
- Capital Outflow: Individual investors have withdrawn capital from Blackstone's flagship private credit fund, BCRED, due to concerns over the investment strategy, although institutional and insurance clients still represent 75% of its credit assets under management.
- Stable Returns: Blackstone has achieved an annual net return of 9.4% in its non-investment-grade private credit strategies since inception, nearly double the leveraged loan market's returns, demonstrating resilience and attractiveness across various market cycles.
- Investment-Grade Expansion: The company grew its investment-grade private credit platform by 23% in the first quarter to $130 million in AUM, indicating a strategic move to leverage its leadership in the non-investment-grade market to explore new investment opportunities.
- Optimistic Market Outlook: Despite negative press, Blackstone remains confident in the investment-grade credit market's future, believing it can continue to deliver premium returns over liquid markets, particularly as capital needs rise in sectors like AI infrastructure development.
See More
BLACKSTONE PRIVATE CREDIT FUND SEEKS SEC APPROVAL FOR UP TO $45 BILLION OFFERING OF CLASS I, CLASS S, AND CLASS D SHARES
- Blackstone Private Credit Fund Filing: Blackstone has filed for an offering of Class I, Class S, and Class D shares of up to $45 billion.
- Investment Opportunity: The filing indicates a significant opportunity for investors to participate in the fund's offerings.
See More
BLACKSTONE PRIVATE CREDIT FUND TO ACQUIRE UP TO 93.1 MILLION SHARES TENDERED BY SHAREHOLDERS AND NOT WITHDRAWN AS OUTLINED IN OFFER
- Fund Purchase Announcement: Blackstone Private Credit Fund plans to purchase up to 93.1 million shares tendered by the fund's shareholders.
- Shareholder Participation: The purchase will be executed for shares that have not been withdrawn, as detailed in the offer.
See More
Blue Owl Capital Shares Surge 9.80% After Strong Q1 Results
- Strong Earnings Beat: Blue Owl Capital reported Q1 2026 earnings with a 14% year-over-year increase to $393.6 million, exceeding market expectations and significantly boosting investor confidence, which led to a share price increase.
- Asset Management Growth: The firm's assets under management rose by 15% to $314.9 billion, indicating robust growth in the private credit sector and enhancing market confidence in its future prospects.
- Surge in Trading Volume: Trading volume reached 68.9 million shares, approximately 100% above the three-month average, reflecting strong market interest and positive investor sentiment towards Blue Owl Capital.
- Market Opportunities: Executives highlighted that despite pressures in private credit, substantial spending by big tech on AI infrastructure presents new opportunities for private credit, which is expected to drive future revenue growth.
See More
Blackstone's $400 Million Investment in Teva: A Strategic Bet
- Investment Scale and Strategic Significance: Blackstone Life Sciences' $400 million investment in Teva Pharmaceuticals in March 2023 reflects strong confidence in the new drug duvakitug, representing not just financial backing but a significant bet on Teva's future development.
- Drug Potential and Clinical Progress: Duvakitug, a monoclonal antibody targeting TL1A, is currently undergoing Phase 3 clinical trials for ulcerative colitis and Crohn's disease, with promising Phase 2 results showing durable efficacy over 44 weeks, indicating a broad market potential.
- Teva's Transformation and Market Recognition: Teva has evolved from a mere generic drug manufacturer to a leader in biopharmaceutical innovation, with credit rating agencies upgrading its rating to BB+, reflecting market confidence in its transformation.
- Opportunities and Risks for Investors: Blackstone's investment not only provides Teva with financial support but may also yield milestone payments and low single-digit royalties on global sales, suggesting that while risk-averse investors might hesitate, aggressive investors could find significant value in Teva, especially if duvakitug succeeds as anticipated.
See More
